{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Schering", "item": "https://www.patentleaderboard.com/2021/company/schering"}, {"@type": "ListItem", "position": 4, "name": "Norbert Schmees", "item": "https://www.patentleaderboard.com/2021/inventor/fl:no_ln:schmees-1"}]}

Home › 2021 › Schering › Norbert Schmees

Norbert Schmees — 1 Patent in 2021

BHBayer Healthcare: 1 patents #78 of 293Top 30%

BPBayer Pharma: 1 patents #72 of 265Top 30%

Berlin, DE: #295 of 1,088 inventorsTop 30%

Overall (2021): #313,965 of 548,734Top 60%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date
11161825	4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides	Jörg WEISKE, Carlo STRESEMANN, Stefan Nikolaus Gradl, Ulrike Röhn, Clara Christ +5 more	2021-11-02

Norbert Schmees — 1 Patent in 2021

Issued Patents 2021

Patent Widget